Safe in Pregnancy / Safe in Children

EBOLA vaccines Efficacy/Effectiveness, Safety and Immunogenicity outcomes, living systematic review and meta-analyses

Ebola & Filovirus Vaccine Pipeline — Interactive Tracker
PHEIC ACTIVE — Bundibugyo ebolavirus (BDBV), DRC & Uganda. WHO declared May 17, 2026. No licensed vaccine for BDBV. Ring vaccination with rVSV-ZEBOV (Ervebo) ongoing — cross-protection unproven in humans.
CEPI LSR · Ebola

Ebola & Filovirus Vaccine Pipeline LSR Tracker · July 2026

Interactive dashboard tracking approved, clinical-stage, and selected preclinical vaccines across Zaire (EBOV), Sudan (SUDV), Bundibugyo (BDBV), Taï Forest (TAFV) and pan-filovirus targets. Click any card for detail and references.
Target virus
Platform
Search
View
Stage notes. Development stages reflect best available public information as of June 2026; verify against ClinicalTrials.gov, WHO ICTRP, and manufacturer pipelines before citing. "Approved" = authorization by SRA and/or WHO prequalification.
Sources. WHO; EMA; FDA; IAVI; Sabin Vaccine Institute; University of Oxford; CEPI (June 2026); Merck/MSD; Janssen; Moderna; peer-reviewed literature 2015–2026. IECS-CONICET Living Systematic Review Unit.

Safe in Pregnancy / Safe in Children

Up-to-date evidence-based information on emerging vaccines in pregnancy and childhood.

Quick Links

Contact Us

Andrea Meyer

ameyer1@tulane.edu

Linkedin
Copyright © 2022. All rights reserved.
Safe in Pregnancy / Safe in Children
Contact Us